Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering ...
Feb 28, 2022
0
142
A diet rich in fiber may help some people being treated for melanoma respond to immunotherapy treatment by influencing the gut microbiome, according to a new study led by researchers at the Center for Cancer Research at the ...
Dec 23, 2021
0
136
Melanoma patients using their smart phone to submit images of lesions to their specialists appears to be a safe and convenient form of follow-up after treatment.
Nov 25, 2021
0
48
An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according to the results of an international, randomized phase III clinical trial led by UPMC Hillman ...
Sep 20, 2021
0
0
Patients with metastatic melanoma that had relapsed on anti-PD-1 therapies or BRAF/MEK inhibitors did not respond as well to an investigational therapy that involves the adoptive cell transfer of tumor-infiltrating lymphocytes ...
Aug 19, 2021
0
47
A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study published in Clinical Cancer Research.
Jul 27, 2021
0
88
Pediatric melanoma is a rare disease with only around 400 cases diagnosed in the United States every year. To better understand this disease and how best to treat it, St. Jude Children's Research Hospital scientists created ...
Jul 6, 2021
0
9
A new article from Liverpool ocular researchers demonstrates that small uveal (intraocular) melanomas are not always harmless, as the current paradigm suggests.
May 19, 2021
0
17
A new study with zebrafish shows that a deadly form of skin cancer—melanoma—alters the metabolism of healthy tissues elsewhere in the body. The research from Washington University in St. Louis suggests that these other ...
May 13, 2021
0
44
A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye, new clinical trial data show.
Apr 20, 2021
0
6
